AstraZeneca Total Long Term Liabilities 2010-2024 | AZN

AstraZeneca total long term liabilities for the quarter ending June 30, 2024 were $36.176B, a 10.45% increase year-over-year.

  • AstraZeneca total long term liabilities for 2023 were $31.411B, a 5.19% decline from 2022.
  • AstraZeneca total long term liabilities for 2022 were $33.132B, a 23.8% decline from 2021.
  • AstraZeneca total long term liabilities for 2021 were $43.482B, a 41.25% increase from 2020.

AstraZeneca Total Long Term Liabilities 2010-2024 | AZN

  • AstraZeneca total long term liabilities for 2023 were $31.411B, a 5.19% decline from 2022.
  • AstraZeneca total long term liabilities for 2022 were $33.132B, a 23.8% decline from 2021.
  • AstraZeneca total long term liabilities for 2021 were $43.482B, a 41.25% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$860.1B
Novo Nordisk (NVO)$592.6B
Johnson & Johnson (JNJ)$400B
AbbVie (ABBV)$340.8B
Merck (MRK)$300.5B
Novartis AG (NVS)$237B
Pfizer (PFE)$168.6B
Sanofi (SNY)$145.6B
Innoviva (INVA)$1.2B